Oligomerix
0 Followers
About
Oligomerix is an emerging biotechnology company focused on developing disease-modifying therapeutics for Alzheimer’s disease and related dementias by targeting tau self-association. The company’s drug discovery platform has identified a pipeline of novel small molecule inhibitors, with preclinical IND-enabling studies in progress for the lead program. Oligomerix’s small molecule approach blocks the formation of al...
- Website
- Headquarters
- Industry
- Social
Org chart
View all (12)James Moe
President and CEO, Co-Founder, Director, Principal Investigator
Eliot J. Davidowitz
Chief Scientific Officer, Co-Founder, and Director
Jack Pasini
Director, Chief Commercial Officer
Robert Foerster
Chief Financial Officer
William Erhardt
Chief Medical Officer
David Dantzker
Director
Douglas N. Durand
Director
Jeffrey N. Bluestein
Director
Peter Davies
Advisor
R.P. Kris Iyer
Advisor
Steven Jacobsen
Advisor
Victor P. Micati
Chairman of the Board
Jobs
View all (0)No jobs yet!
Wires
View all (0)No wires yet!
By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.